AUG 18, 2026 · PHASE 3 TRIAL
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
ClinicalTrials.gov
This is a Phase 3 trial registration with no results posted; the study is actively recruiting and has not yet reported outcomes, making it an early-stage record describing a planned intervention.
Reported
Planned enrollment1800
PhasePHASE 3
Primary outcome measureTime to first event of CV death, HF event,…